Albireo Pharma Current Ratio 2007-2021 | ALBO

Albireo Pharma current ratio from 2007 to 2021. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Albireo Pharma Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2021-06-30 $0.20B $0.03B 7.23
2021-03-31 $0.23B $0.02B 10.17
2020-12-31 $0.26B $0.03B 10.36
2020-09-30 $0.29B $0.02B 13.52
2020-06-30 $0.16B $0.02B 9.29
2020-03-31 $0.16B $0.02B 10.45
2019-12-31 $0.14B $0.02B 7.49
2019-09-30 $0.15B $0.01B 12.01
2019-06-30 $0.16B $0.01B 13.83
2019-03-31 $0.15B $0.01B 15.53
2018-12-31 $0.17B $0.01B 13.07
2018-09-30 $0.18B $0.01B 19.41
2018-06-30 $0.19B $0.01B 23.53
2018-03-31 $0.20B $0.01B 27.25
2017-12-31 $0.06B $0.01B 6.94
2017-09-30 $0.06B $0.01B 7.33
2017-06-30 $0.06B $0.01B 8.64
2017-03-31 $0.02B $0.01B 2.35
2016-12-31 $0.03B $0.01B 2.43
2016-09-30 $0.00B 0.00
2016-06-30 $0.03B $0.00B 11.31
2016-03-31 $0.03B $0.00B 15.45
2015-12-31 $0.04B $0.00B 26.50
2015-09-30 $0.04B $0.00B 22.74
2015-06-30 $0.05B $0.00B 17.75
2015-03-31 $0.02B $0.00B 8.74
2014-12-31 $0.02B $0.00B 12.20
2014-09-30 $0.03B $0.00B 15.41
2014-06-30 $0.03B $0.00B 12.78
2014-03-31 $0.03B $0.00B 15.91
2013-12-31 $0.04B $0.00B 11.89
2013-09-30 $0.04B $0.00B 16.42
2013-06-30 $0.04B $0.00B 16.87
2013-03-31 $0.03B $0.00B 14.75
2012-12-31 $0.04B $0.00B 8.35
2012-09-30 $0.04B $0.00B 14.22
2012-06-30 $0.05B $0.00B 16.33
2012-03-31 $0.03B $0.00B 11.82
2011-12-31 $0.04B $0.00B 10.27
2011-09-30 $0.04B $0.00B 11.92
2011-06-30 $0.04B $0.00B 13.20
2011-03-31 $0.02B $0.00B 6.06
2010-12-31 $0.03B $0.01B 4.63
2010-09-30 $0.03B $0.00B 6.74
2010-06-30 $0.03B $0.01B 5.23
2010-03-31 $0.04B $0.01B 4.91
2009-12-31 $0.04B $0.01B 7.81
2009-09-30 $0.06B $0.01B 6.15
2009-06-30 $0.07B $0.01B 7.04
2009-03-31 $0.08B $0.01B 8.20
2008-12-31 $0.08B $0.01B 10.55
2008-09-30 $0.09B $0.01B 10.35
2008-06-30 $0.09B $0.01B 14.50
2008-03-31 $0.11B $0.01B 16.65
2007-12-31 $0.07B $0.01B 10.51
2007-09-30 $0.08B $0.01B 15.24
2007-06-30 $0.09B $0.00B 25.41
2007-03-31 $0.01B $0.00B 2.74
2006-12-31 $0.00B 0.00
2006-09-30 $0.02B $0.00B 7.62
2006-06-30 $0.00B 0.00
2006-03-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.563B $0.008B
Albireo Pharma, Inc. is a biopharmaceutical company. It focused on the development of novel bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders. Albireo Pharma Inc., formerly known as BIODEL INC., is based in Boston, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $127.994B 8.52
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.309B 20.85
Biohaven Pharmaceutical Holding (BHVN) United States $9.150B 0.00
Emergent Biosolutions (EBS) United States $2.677B 6.46
Arcus Biosciences (RCUS) United States $2.522B 0.00
Myovant Sciences (MYOV) United Kingdom $1.905B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.799B 0.00
Zymeworks (ZYME) Canada $1.071B 0.00
Ambrx Biopharma (AMAM) United States $0.474B 0.00
SQZ Biotechnologies (SQZ) United States $0.341B 0.00
Enzo Biochem (ENZ) United States $0.160B 15.76